Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Effect on Inflammation and Cardiovascular Risk in HIV
NCT05085834Phase 1Completed
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jan 2020
- Primary completion
- Aug 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in zinc deficiency comparing Zinc gluconate with Placebo (2 arms). Primary endpoints: Zinc Levels at 24 weeks, Inflammation and Immune Activation at 24 weeks and 2 more. Started Jan 2020; status: completed.
02
Drugs
zinc gluconate
03
Conditions
zinc deficiency
Beyond the preview
Go deeper on NCT05085834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05085834.